Read original at:
hightimes.com
In a detailed feature, High Times explores the strategic vision behind Rare Cannabinoid Company, a brand that anticipated the market's evolution beyond CBD. The article from High Times chronicles how founders Jennifer Carlile and Jared Dalgamouni shifted focus from a broad-spectrum CBD brand to pioneering formulations with lesser-known compounds like CBN, CBG, and THCV. It highlights their commitment to education, targeted wellness, and Hawaiian-grown hemp, positioning them ahead of the curve in the volatile hemp industry. The piece underscores a long-term bet on the complexity and future of cannabinoid science. For an in-depth look at this innovative approach, read the full article on High Times.
